Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis. - Vogiatzi F; Heymann J; Müller K; Winterberg D; Drakul A; Rösner T; Lenk L; Heib M; Gehlert CL; Cario G; Schrappe M; Claviez A; et al. (Blood advances, 2022)